Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 84301-84350 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05240950
Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases
PHASE1Recruiting
18 participants
Started: Aug 25, 2022 · Completed: Dec 25, 2026
2 conditions1 sponsor1 location
NCT05192889
Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
PHASE1/PHASE2Active, not recruiting
35 participants
Started: Aug 25, 2022 · Completed: Feb 28, 2027
2 conditions2 sponsors2 locations
NCT06047821
Enterics for Global Health (EFGH)
N/AActive, not recruiting
9,800 participants
Started: Aug 25, 2022 · Completed: Apr 30, 2025
3 conditions11 sponsors33 locations
NCT06163729
Camrelizumab Combined With Chemotherapy and Radiotherapy Perioperative Treatment of Esophageal Gastric Junction Adenocarcinoma
PHASE2Recruiting
68 participants
Started: Aug 25, 2022 · Completed: May 1, 2028
1 condition1 sponsor1 location
NCT05698290
HELP Pain Training Program
N/AActive, not recruiting
68 participants
Started: Aug 25, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05230810
Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.
PHASE1/PHASE2Recruiting
40 participants
Started: Aug 25, 2022 · Completed: Jun 30, 2025
1 condition3 sponsors4 locations
NCT06114589
A Study to Develop Molecular Integrated Predictive Models of Breast Radio-toxicity (Precise-RTox)
N/ARecruiting
420 participants
Started: Aug 25, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04852601
ToolBox Detect: Low Cost Detection of Cognitive Decline in Primary Care Settings
NARecruiting
41,500 participants
Started: Aug 25, 2022 · Completed: May 31, 2026
2 conditions2 sponsors1 location
NCT05052216
Development of a Wearable Point of Care Monitoring Device for Pediatric Obstructive Sleep Apnea
N/ARecruiting
120 participants
Started: Aug 25, 2022 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT05574036
Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients With Hyperuricemia
PHASE2Active, not recruiting
70 participants
Started: Aug 25, 2022 · Completed: Dec 25, 2026
2 conditions1 sponsor1 location
NCT05417321
A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
80 participants
Started: Aug 25, 2022 · Completed: Aug 1, 2025
2 conditions1 sponsor4 locations
NCT05234567
A Prospective Sub-Study of the Global Hypophosphatasia Registry
N/ARecruiting
30 participants
Started: Aug 25, 2022 · Completed: Jul 18, 2028
1 condition1 sponsor12 locations
NCT06259500
Patient-derived Stem Cell Models of Anorexia Nervosa
N/AActive, not recruiting
20 participants
Started: Aug 25, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05162677
Prophylactic Mastectomy: Prospective Evaluation of the Correlation Between Skin Flap Thickness, Residual Glandular Tissue and Skin Necrosis by Imaging and Clinical Examination
N/ARecruiting
45 participants
Started: Aug 25, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05185739
Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)
PHASE2Recruiting
60 participants
Started: Aug 25, 2022 · Completed: Jul 31, 2030
1 condition2 sponsors11 locations
NCT05364372
SMLI With Hispanic Cancer Survivors and Caregivers
NARecruiting
217 participants
Started: Aug 25, 2022 · Completed: Mar 1, 2026
2 conditions2 sponsors1 location
NCT05468138
PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery
PHASE2Not yet recruiting
141 participants
Started: Aug 25, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT05774275
The Combination of Radiotherapy, Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue Sarcoma
PHASE1/PHASE2Recruiting
52 participants
Started: Aug 25, 2022 · Completed: Aug 24, 2029
1 condition1 sponsor1 location
NCT05512286
Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap Reconstruction
NARecruiting
80 participants
Started: Aug 25, 2022 · Completed: Oct 1, 2027
1 condition7 sponsors6 locations
NCT05240807
Clinical Impact of Cardiac Photon Counting CT
NAActive, not recruiting
450 participants
Started: Aug 24, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05510141
Virtual Reality Games in Pediatric Surgery
NARecruiting
100 participants
Started: Aug 24, 2022 · Completed: Oct 1, 2024
3 conditions1 sponsor1 location
NCT05445323
Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia
PHASE1/PHASE2Active, not recruiting
8 participants
Started: Aug 24, 2022 · Completed: Sep 30, 2029
2 conditions1 sponsor3 locations
NCT06637267
Prospective Evaluation of Proclarix® Test to Improve Risk Stratification in Men Scheduled for MpMRI and Prostate Biopsy in Cantonal Hospital Aarau
N/ARecruiting
480 participants
Started: Aug 24, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05546593
Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With Gout
N/ARecruiting
200 participants
Started: Aug 24, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05350722
Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients
NARecruiting
100 participants
Started: Aug 24, 2022 · Completed: Dec 31, 2037
1 condition2 sponsors7 locations
NCT05224778
DMCRN-02-001: Assessing Pediatric Endpoints in DM1
N/ARecruiting
50 participants
Started: Aug 24, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor5 locations
NCT06255977
A Study Evaluating the Safety and Efficacy of Neuroprotective Peptide CN-105 Peptide in Patients With Acute Supratentorial Intracerebral Hemorrhage
PHASE2Recruiting
240 participants
Started: Aug 24, 2022 · Completed: Aug 31, 2024
1 condition2 sponsors1 location
NCT05156983
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
PHASE3Recruiting
328 participants
Started: Aug 24, 2022 · Completed: Apr 12, 2028
1 condition2 sponsors49 locations
NCT05814159
A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)
PHASE3Active, not recruiting
15 participants
Started: Aug 24, 2022 · Completed: Jun 24, 2026
2 conditions2 sponsors8 locations
NCT06868888
Rheological Functions of Erythrocyte in ESRD
N/ARecruiting
40 participants
Started: Aug 24, 2022 · Completed: Mar 26, 2025
1 condition1 sponsor1 location
NCT05430230
Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis
PHASE4Active, not recruiting
20 participants
Started: Aug 24, 2022 · Completed: Sep 1, 2026
1 condition1 sponsor1 location
NCT05525598
Internet-based Treatment for Patients Suffering From Severe Functional Somatic Disorders
NARecruiting
166 participants
Started: Aug 24, 2022 · Completed: Oct 31, 2026
6 conditions3 sponsors1 location
NCT06439823
Controlled Study of Upper and Lower Limb Movements in Patients Patients with Pathologies That Have an Impact on Ambulation or Motor Function
NARecruiting
200 participants
Started: Aug 24, 2022 · Completed: Aug 31, 2028
1 condition2 sponsors1 location
NCT05507151
Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
N/ARecruiting
30 participants
Started: Aug 24, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT05686941
Is Laryngeal Ultrasound Useful in the Assessment for ILO? A Protocol for a Two-stage Exploratory Pilot Study
N/ARecruiting
60 participants
Started: Aug 24, 2022 · Completed: Jun 27, 2025
4 conditions5 sponsors1 location
NCT05509569
A Survey of Icatibant in Pediatric Participants with Hereditary Angioedema
N/AActive, not recruiting
32 participants
Started: Aug 24, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05361395
First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
PHASE1Active, not recruiting
184 participants
Started: Aug 24, 2022 · Completed: Aug 28, 2028
1 condition1 sponsor44 locations
NCT05922670
The BH-Works Suicide Prevention Program for Sexual and Gender Minority Youth
NAEnrolling by invitation
260 participants
Started: Aug 24, 2022 · Completed: Aug 24, 2026
2 conditions6 sponsors5 locations
NCT04802161
Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes
PHASE2Active, not recruiting
50 participants
Started: Aug 24, 2022 · Completed: Apr 25, 2026
6 conditions1 sponsor11 locations
NCT04839705
Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device
NARecruiting
180 participants
Started: Aug 24, 2022 · Completed: Dec 31, 2029
1 condition1 sponsor29 locations
NCT05454293
One Talk at a Time: A Racial-ethnic Socialization Intervention for Diverse Families
NARecruiting
312 participants
Started: Aug 24, 2022 · Completed: Jun 30, 2025
4 conditions1 sponsor1 location
NCT05838261
Prospective Evaluation of Speech Function Through Patient- and Parent-response Outcome Measurements in Velopharyngeal Insufficiency
N/ARecruiting
50 participants
Started: Aug 24, 2022 · Completed: Jan 1, 2026
1 condition6 sponsors6 locations
NCT06380855
Flexible Colonoscope Assisted Hybrid Transanal Total Mesorectal Resection (taTME)
N/ARecruiting
5 participants
Started: Aug 24, 2022 · Completed: Aug 24, 2025
1 condition1 sponsor1 location
NCT05246098
REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or ARI
N/ARecruiting
900 participants
Started: Aug 24, 2022 · Completed: Oct 1, 2025
3 conditions3 sponsors28 locations
NCT05151835
Novel Robotic Surgical System for Minimally Invasive Surgery
NARecruiting
20 participants
Started: Aug 24, 2022 · Completed: Jan 30, 2024
1 condition1 sponsor1 location
NCT05165056
Photobiomodulation Therapy in the Prevention and Management of Radiotherapy-induced Vaginal Toxicity
NARecruiting
62 participants
Started: Aug 24, 2022 · Completed: Jan 31, 2030
2 conditions3 sponsors2 locations
NCT05397093
ITIL-306 in Advanced Solid Tumors
PHASE1Active, not recruiting
51 participants
Started: Aug 24, 2022 · Completed: Nov 30, 2039
3 conditions1 sponsor2 locations
NCT05399888
A Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age
PHASE2Active, not recruiting
416 participants
Started: Aug 24, 2022 · Completed: Jan 8, 2029
2 conditions1 sponsor138 locations
NCT05498376
The Leadless AV Versus DDD Pacing Study
PHASE4Recruiting
100 participants
Started: Aug 23, 2022 · Completed: Dec 31, 2027
4 conditions2 sponsors1 location
NCT05477849
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients with Solid Tumors
PHASE1Recruiting
30 participants
Started: Aug 23, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location